cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.30910946
title: Supplementary Material for: Primary Embryonal Rhabdomyosarcoma of the Breast: a case report and literature review

description: Background: Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children and adolescents, but primary RMS of the breast is exceptionally rare and diagnostically challenging. Imaging findings are nonspecific and can mimic benign adolescent lesions (e.g., fibroadenoma), making timely histopathologic confirmation crucial. Immunohistochemistry for muscle markers—particularly Desmin and Myogenin—supports definitive diagnosis of embryonal RMS (ERMS). 
Case Presentation: A 14-year-old Arab female presented with a rapidly enlarging left-breast mass and ipsilateral axillary lymphadenopathy. Core biopsy showed small round blue cells with rhabdomyoblastic differentiation; tumor cells were Desmin- and Myogenin-positive, consistent with ERMS. She received six cycles of MAID chemotherapy, followed by local recurrence; one cycle of ICE achieved ~50% partial response but was complicated by cystitis and rapid radiologic progression. After three cycles of VAC, she underwent total mastectomy with lymph-node dissection. Restaging FDG-PET/CT demonstrated local recurrence and nodal metastases (bilateral axillary, subpectoral, internal mammary) with pulmonary nodules. Despite multimodal therapy, the disease remained refractory and the patient ultimately died of complications from metastatic RMS. 
Case Discussion: This case highlights the aggressive biology of primary breast ERMS in adolescents and the risk of early recurrence and dissemination despite intensive therapy. While standard management of RMS is multimodal—systemic chemotherapy with surgical resection and/or radiotherapy—responses can be transient, and treatment interruptions (e.g., toxicity-related delays) may jeopardize disease control. The diagnostic value of Myogenin (highly specific for rhabdomyoblastic differentiation) and Desmin was pivotal here, while the clinical course underscores the limitations of currently available regimens (MAID, ICE, VAC) for refractory disease at this uncommon site. 
Conclusion: Primary embryonal RMS of the breast is rare and highly aggressive, with a strong propensity for local recurrence and metastatic spread. Even with aggressive multimodal therapy, outcomes can be poor. Earlier recognition, rigorous treatment delivery, and development of novel strategies are urgently needed to improve survival in this devastating presentation.
DOI: 10.6084/m9.figshare.30910946.v1
title: Supplementary Material for: Primary Embryonal Rhabdomyosarcoma of the Breast: a case report and literature review

description: Background: Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children and adolescents, but primary RMS of the breast is exceptionally rare and diagnostically challenging. Imaging findings are nonspecific and can mimic benign adolescent lesions (e.g., fibroadenoma), making timely histopathologic confirmation crucial. Immunohistochemistry for muscle markers—particularly Desmin and Myogenin—supports definitive diagnosis of embryonal RMS (ERMS). 
Case Presentation: A 14-year-old Arab female presented with a rapidly enlarging left-breast mass and ipsilateral axillary lymphadenopathy. Core biopsy showed small round blue cells with rhabdomyoblastic differentiation; tumor cells were Desmin- and Myogenin-positive, consistent with ERMS. She received six cycles of MAID chemotherapy, followed by local recurrence; one cycle of ICE achieved ~50% partial response but was complicated by cystitis and rapid radiologic progression. After three cycles of VAC, she underwent total mastectomy with lymph-node dissection. Restaging FDG-PET/CT demonstrated local recurrence and nodal metastases (bilateral axillary, subpectoral, internal mammary) with pulmonary nodules. Despite multimodal therapy, the disease remained refractory and the patient ultimately died of complications from metastatic RMS. 
Case Discussion: This case highlights the aggressive biology of primary breast ERMS in adolescents and the risk of early recurrence and dissemination despite intensive therapy. While standard management of RMS is multimodal—systemic chemotherapy with surgical resection and/or radiotherapy—responses can be transient, and treatment interruptions (e.g., toxicity-related delays) may jeopardize disease control. The diagnostic value of Myogenin (highly specific for rhabdomyoblastic differentiation) and Desmin was pivotal here, while the clinical course underscores the limitations of currently available regimens (MAID, ICE, VAC) for refractory disease at this uncommon site. 
Conclusion: Primary embryonal RMS of the breast is rare and highly aggressive, with a strong propensity for local recurrence and metastatic spread. Even with aggressive multimodal therapy, outcomes can be poor. Earlier recognition, rigorous treatment delivery, and development of novel strategies are urgently needed to improve survival in this devastating presentation.
DOI: 10.13130/rd_unimi/ewftha/sfwegy
title: Febbraio_1906_Pagina_031.jpg

description: Bulletin of 1906/02/08
DOI: 10.13130/rd_unimi/zbysir/n3fqjr
title: Febbraio_1900_Pagina_041.jpg

description: Bulletin of 1900/02/11
DOI: 10.3535/3sq-2r0-3nf
title: Miltochrista miniata (Forster, 1771)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/w70-b3r-yfj
title: Achlya flavicornis (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.13130/rd_unimi/6g4l2b/cpbe2c
title: Febbraio_1904_Pagina_040.jpg

description: Bulletin of 1904/02/10
DOI: 10.13130/rd_unimi/cea2oy/6jm3ub
title: Febbraio_1888_Pagina_066.jpg

description: Bulletin of 1888/02/17
DOI: 10.13130/rd_unimi/ewftha/rkqckj
title: Febbraio_1906_Pagina_032.jpg

description: Bulletin of 1906/02/08
DOI: 10.13130/rd_unimi/zbysir/ageqdi
title: Febbraio_1900_Pagina_042.jpg

description: Bulletin of 1900/02/11
DOI: 10.3535/d3r-7re-v8g
title: Speyeria aglaja (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/z0d-hxv-t0x
title: Orgyia (Orgyia) antiqua (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.6084/m9.figshare.30910949
title: Supplementary Material for: Early Safety Results from the Phase 3b SIERRA Study of Durvalumab and Tremelimumab as First-Line Treatment for Participants with Unresectable Hepatocellular Carcinoma and a Poor Prognosis

description: Background:
Subgroups of people with unresectable hepatocellular carcinoma (uHCC) are often excluded from clinical trials due to adverse prognostic factors. The SIERRA (NCT05883644) study assesses the efficacy and safety of STRIDE (Single Tremelimumab Regular Interval Durvalumab) in clinically-relevant subgroups of uHCC with poorer prognosis, including participants with more decompensated hepatic function, worse performance status, or more advanced disease than the HIMALAYA (NCT03298451) study.
Methods:
SIERRA is a Phase 3b, single-arm, multicenter study that enrolled participants with uHCC with: Child-Pugh (CP) class of B7 or B8 with Eastern Cooperative Oncology Group performance status (ECOG PS) 0–1, without main trunk portal vein thrombosis (PVT) (CP B7/B8 cohort); CP class A with ECOG PS 2, without main trunk PVT (ECOG PS 2 cohort); or CP class A with ECOG PS 0–1 with evidence of chronic main trunk PVT (Vp4 cohort). Participants received STRIDE (tremelimumab 300 mg plus durvalumab 1500 mg once followed by durvalumab 1500 mg every 4 weeks). This pre-planned early safety analysis occurred once ~60 participants had been followed for ≥6 months (data cut-off: September 27, 2024). Co-primary endpoints are incidence of Grade 3/4 adverse events (AEs) possibly related to study treatment (PRAEs) within 6 months of treatment initiation and objective response rate. The study is ongoing.
Results:
This analysis included 98 participants (CP B7/B8 cohort, n = 35; ECOG PS 2 cohort, n = 44; Vp4 cohort, n = 19). Median (Q1–Q3) number of cycles of durvalumab was 4.0 (2.0–8.0). Incidence of Grade 3/4 PRAEs occurring within 6 months of treatment was 19.4% (95% confidence interval, 12.1–28.6) overall. Incidence of serious AEs was 32.7%. PRAEs leading to death occurred in 2.0% of participants.
Conclusions:
The safety profile of STRIDE was manageable and consistent with the HIMALAYA study in participants with poorer prognosis than in HIMALAYA.
DOI: 10.13130/rd_unimi/6g4l2b/wtovln
title: Febbraio_1904_Pagina_041.jpg

description: Bulletin of 1904/02/11
DOI: 10.13130/rd_unimi/cea2oy/lvjvo1
title: Febbraio_1888_Pagina_067.jpg

description: Bulletin of 1888/02/17
DOI: 10.13130/rd_unimi/ewftha/miehcg
title: Febbraio_1906_Pagina_033.jpg

description: Bulletin of 1906/02/09
DOI: 10.3535/9c6-vry-bgw
title: Indalia lutarella (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.6084/m9.figshare.30910949.v1
title: Supplementary Material for: Early Safety Results from the Phase 3b SIERRA Study of Durvalumab and Tremelimumab as First-Line Treatment for Participants with Unresectable Hepatocellular Carcinoma and a Poor Prognosis

description: Background:
Subgroups of people with unresectable hepatocellular carcinoma (uHCC) are often excluded from clinical trials due to adverse prognostic factors. The SIERRA (NCT05883644) study assesses the efficacy and safety of STRIDE (Single Tremelimumab Regular Interval Durvalumab) in clinically-relevant subgroups of uHCC with poorer prognosis, including participants with more decompensated hepatic function, worse performance status, or more advanced disease than the HIMALAYA (NCT03298451) study.
Methods:
SIERRA is a Phase 3b, single-arm, multicenter study that enrolled participants with uHCC with: Child-Pugh (CP) class of B7 or B8 with Eastern Cooperative Oncology Group performance status (ECOG PS) 0–1, without main trunk portal vein thrombosis (PVT) (CP B7/B8 cohort); CP class A with ECOG PS 2, without main trunk PVT (ECOG PS 2 cohort); or CP class A with ECOG PS 0–1 with evidence of chronic main trunk PVT (Vp4 cohort). Participants received STRIDE (tremelimumab 300 mg plus durvalumab 1500 mg once followed by durvalumab 1500 mg every 4 weeks). This pre-planned early safety analysis occurred once ~60 participants had been followed for ≥6 months (data cut-off: September 27, 2024). Co-primary endpoints are incidence of Grade 3/4 adverse events (AEs) possibly related to study treatment (PRAEs) within 6 months of treatment initiation and objective response rate. The study is ongoing.
Results:
This analysis included 98 participants (CP B7/B8 cohort, n = 35; ECOG PS 2 cohort, n = 44; Vp4 cohort, n = 19). Median (Q1–Q3) number of cycles of durvalumab was 4.0 (2.0–8.0). Incidence of Grade 3/4 PRAEs occurring within 6 months of treatment was 19.4% (95% confidence interval, 12.1–28.6) overall. Incidence of serious AEs was 32.7%. PRAEs leading to death occurred in 2.0% of participants.
Conclusions:
The safety profile of STRIDE was manageable and consistent with the HIMALAYA study in participants with poorer prognosis than in HIMALAYA.
DOI: 10.13130/rd_unimi/6g4l2b/tohdsz
title: Febbraio_1904_Pagina_042.jpg

description: Bulletin of 1904/02/11
DOI: 10.13130/rd_unimi/cea2oy/awf8ht
title: Febbraio_1888_Pagina_068.jpg

description: Bulletin of 1888/02/17
DOI: 10.13130/rd_unimi/zbysir/axe6ek
title: Febbraio_1900_Pagina_043.jpg

description: Bulletin of 1900/02/11
DOI: 10.3535/ay6-xh4-n17
title: Crypsedra gemmea Treitschke, 1825

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.6084/m9.figshare.30910952
title: Supplementary Material for: Utility of biomarker panels in the surveillance and monitoring of hepatocellular carcinoma: Consensus Statements from an International Delphi Panel

description: Hepatocellular carcinoma (HCC) surveillance is recommended using a combination of abdominal ultrasound plus alpha-fetoprotein (AFP) in patients with chronic hepatitis B or cirrhosis from any etiology. However, this strategy is limited by suboptimal sensitivity for early-stage HCC, particularly in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated liver disease (ALD). Phase 2 and phase 3 biomarker studies have reported the promise of novel blood-based biomarkers, including alpha fetoprotein (AFP), des-gamma-carboxy prothrombin (DCP), and lens culinaris agglutinin-reactive alpha-fetoprotein (AFP-L3). Biomarker panels, such as the GALAD score, GAAD, and ASAP combine these biomarkers plus age and gender into biomarker panels. A panel of 10 experts from Asia and the USA convened to discuss the clinical utility of these biomarkers for detecting early-stage HCC. The experts agreed that biomarker panels have shown higher sensitivity than each individual biomarker and showed promise for early-stage HCC detection, particularly in those with a high proportion of patients with obesity and MASLD and geographies with insufficient access to high quality ultrasound. However, biomarkers require prospective validation in clinical utility trials demonstrating net benefit in patients with cirrhosis, and implementation may face challenges including widespread access to testing, broader insurance coverage, and improving awareness among physicians and patients.
DOI: 10.13130/rd_unimi/ewftha/8hnjsy
title: Febbraio_1906_Pagina_034.jpg

description: Bulletin of 1906/02/09
DOI: 10.13130/rd_unimi/zbysir/9vtcla
title: Febbraio_1900_Pagina_044.jpg

description: Bulletin of 1900/02/11
DOI: 10.3535/7me-6lh-408
title: Eurgaphe subrosea

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/a69-zq6-38s
title: Xylena (Lithomoia) solidaginis Hübner, 1803

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.6084/m9.figshare.30910952.v1
title: Supplementary Material for: Utility of biomarker panels in the surveillance and monitoring of hepatocellular carcinoma: Consensus Statements from an International Delphi Panel

description: Hepatocellular carcinoma (HCC) surveillance is recommended using a combination of abdominal ultrasound plus alpha-fetoprotein (AFP) in patients with chronic hepatitis B or cirrhosis from any etiology. However, this strategy is limited by suboptimal sensitivity for early-stage HCC, particularly in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated liver disease (ALD). Phase 2 and phase 3 biomarker studies have reported the promise of novel blood-based biomarkers, including alpha fetoprotein (AFP), des-gamma-carboxy prothrombin (DCP), and lens culinaris agglutinin-reactive alpha-fetoprotein (AFP-L3). Biomarker panels, such as the GALAD score, GAAD, and ASAP combine these biomarkers plus age and gender into biomarker panels. A panel of 10 experts from Asia and the USA convened to discuss the clinical utility of these biomarkers for detecting early-stage HCC. The experts agreed that biomarker panels have shown higher sensitivity than each individual biomarker and showed promise for early-stage HCC detection, particularly in those with a high proportion of patients with obesity and MASLD and geographies with insufficient access to high quality ultrasound. However, biomarkers require prospective validation in clinical utility trials demonstrating net benefit in patients with cirrhosis, and implementation may face challenges including widespread access to testing, broader insurance coverage, and improving awareness among physicians and patients.
DOI: 10.13130/rd_unimi/6g4l2b/wtrs4t
title: Febbraio_1904_Pagina_043.jpg

description: Bulletin of 1904/02/11
DOI: 10.13130/rd_unimi/cea2oy/zf9thv
title: Febbraio_1888_Pagina_069.jpg

description: Bulletin of 1888/02/18
DOI: 10.3535/ak8-zdz-svh
title: Photedes fluxa Hübner, 1809

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.13130/rd_unimi/6g4l2b/vx3yzv
title: Febbraio_1904_Pagina_044.jpg

description: Bulletin of 1904/02/11
DOI: 10.13130/rd_unimi/ewftha/kpin70
title: Febbraio_1906_Pagina_035.jpg

description: Bulletin of 1906/02/09
DOI: 10.13130/rd_unimi/zbysir/2h7scp
title: Febbraio_1900_Pagina_045.jpg

description: Bulletin of 1900/02/12
DOI: 10.3535/3ew-72j-csb
title: Lygephila (Lygephila) viciae Hübner, 1822

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/mbg-1c6-agc
title: Anthocharis cardamines (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.13130/rd_unimi/cea2oy/ql2qvf
title: Febbraio_1888_Pagina_070.jpg

description: Bulletin of 1888/02/18
DOI: 10.13130/rd_unimi/ewftha/nkqp1p
title: Febbraio_1906_Pagina_036.jpg

description: Bulletin of 1906/02/09
DOI: 10.3535/rva-nxn-5n7
title: Hydraecia nordstroemi Horke, 1952

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.13130/rd_unimi/6g4l2b/h6ldh2
title: Febbraio_1904_Pagina_045.jpg

description: Bulletin of 1904/02/12
DOI: 10.13130/rd_unimi/cea2oy/fghjut
title: Febbraio_1888_Pagina_071.jpg

description: Bulletin of 1888/02/18
DOI: 10.13130/rd_unimi/ewftha/hktw7z
title: Febbraio_1906_Pagina_037.jpg

description: Bulletin of 1906/02/10
DOI: 10.13130/rd_unimi/zbysir/m0gfc2
title: Febbraio_1900_Pagina_046.jpg

description: Bulletin of 1900/02/12
DOI: 10.3535/4x0-caw-b3v
title: Dioryctria schutzeella Fuchs, 1899

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/ys5-14b-gxc
title: Hydraecia nordstroemi Horke, 1952

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.13130/rd_unimi/6g4l2b/b4joav
title: Febbraio_1904_Pagina_046.jpg

description: Bulletin of 1904/02/12
DOI: 10.13130/rd_unimi/zbysir/lnoqqa
title: Febbraio_1900_Pagina_047.jpg

description: Bulletin of 1900/02/12
DOI: 10.3535/0fl-tw9-r5t
title: Euphydryas Scudder, 1872

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/mgp-hst-e0b
title: Achlya flavicornis (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.13130/rd_unimi/6g4l2b/lilhcm
title: Febbraio_1904_Pagina_047.jpg

description: Bulletin of 1904/02/12
DOI: 10.13130/rd_unimi/cea2oy/hgrofm
title: Febbraio_1888_Pagina_072.jpg

description: Bulletin of 1888/02/18
DOI: 10.13130/rd_unimi/ewftha/dq8txp
title: Febbraio_1906_Pagina_038.jpg

description: Bulletin of 1906/02/10
DOI: 10.13130/rd_unimi/zbysir/cpld1e
title: Febbraio_1900_Pagina_048.jpg

description: Bulletin of 1900/02/12
DOI: 10.3535/4vx-nty-gls
title: Euphydryas Scudder, 1872

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.13130/rd_unimi/cea2oy/gxmrhv
title: Febbraio_1888_Pagina_073.jpg

description: Bulletin of 1888/02/19
DOI: 10.13130/rd_unimi/ewftha/tmfahp
title: Febbraio_1906_Pagina_039.jpg

description: Bulletin of 1906/02/10
DOI: 10.3535/0j6-ca4-jgn
title: Catocala sponsa Linnaeus, 1767

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/0pc-ryq-7m4
title: Conistra (Conistra) vaccinii (Linnaeus, 1761)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.13130/rd_unimi/6g4l2b/nnwdr5
title: Febbraio_1904_Pagina_048.jpg

description: Bulletin of 1904/02/12
DOI: 10.13130/rd_unimi/cea2oy/enynre
title: Febbraio_1888_Pagina_074.jpg

description: Bulletin of 1888/02/19
DOI: 10.13130/rd_unimi/ewftha/znfyfn
title: Febbraio_1906_Pagina_040.jpg

description: Bulletin of 1906/02/10
DOI: 10.13130/rd_unimi/zbysir/7dp8ge
title: Febbraio_1900_Pagina_049.jpg

description: Bulletin of 1900/02/13
DOI: 10.3535/6wj-7p1-398
title: Litophane hepatica (Clerck, 1759)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/qb2-856-67v
title: Xylena vetusta Hübner, 1813

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.13130/rd_unimi/6g4l2b/gd5zlf
title: Febbraio_1904_Pagina_049.jpg

description: Bulletin of 1904/02/13
DOI: 10.13130/rd_unimi/zbysir/l7r4is
title: Febbraio_1900_Pagina_050.jpg

description: Bulletin of 1900/02/13
DOI: 10.3535/lk2-pfv-j19
title: Ortholepis Ragonot, 1887

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.13130/rd_unimi/cea2oy/pbahej
title: Febbraio_1888_Pagina_075.jpg

description: Bulletin of 1888/02/19
DOI: 10.13130/rd_unimi/ewftha/nuhvya
title: Febbraio_1906_Pagina_041.jpg

description: Bulletin of 1906/02/11
DOI: 10.13130/rd_unimi/zbysir/uctuha
title: Febbraio_1900_Pagina_051.jpg

description: Bulletin of 1900/02/13
DOI: 10.3535/a0c-d7r-y4t
title: Xestia (Xestia) collina Boisduval, 1840

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/ycc-01s-zvt
title: Litophane hepatica (Clerck, 1759)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.13130/rd_unimi/6g4l2b/wumsyt
title: Febbraio_1904_Pagina_050.jpg

description: Bulletin of 1904/02/13
DOI: 10.13130/rd_unimi/cea2oy/wz0hox
title: Febbraio_1888_Pagina_076.jpg

description: Bulletin of 1888/02/19
DOI: 10.13130/rd_unimi/ewftha/cwjrag
title: Febbraio_1906_Pagina_042.jpg

description: Bulletin of 1906/02/11
DOI: 10.3535/9cy-7ym-nv1
title: Achroia grisella (Fabricius, 1794)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.13130/rd_unimi/6g4l2b/vohk3y
title: Febbraio_1904_Pagina_051.jpg

description: Bulletin of 1904/02/13
DOI: 10.13130/rd_unimi/zbysir/rneoz2
title: Febbraio_1900_Pagina_052.jpg

description: Bulletin of 1900/02/13
DOI: 10.3535/f2v-elf-m18
title: Scopariinae

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/jpg-xb7-wfj
title: Dryobotodes (Dryobotodes) eremita Fabricius, 1775

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.13130/rd_unimi/6g4l2b/tcpilu
title: Febbraio_1904_Pagina_052.jpg

description: Bulletin of 1904/02/13
DOI: 10.13130/rd_unimi/cea2oy/tyue0d
title: Febbraio_1888_Pagina_077.jpg

description: Bulletin of 1888/02/20
DOI: 10.13130/rd_unimi/ewftha/ltyp91
title: Febbraio_1906_Pagina_043.jpg

description: Bulletin of 1906/02/11
DOI: 10.13130/rd_unimi/zbysir/w3z57x
title: Febbraio_1900_Pagina_053.jpg

description: Bulletin of 1900/02/14
DOI: 10.3535/nx4-q1n-rha
title: Clostera pigra (Hufnagel, 1766)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.13130/rd_unimi/cea2oy/tntbds
title: Febbraio_1888_Pagina_078.jpg

description: Bulletin of 1888/02/20
DOI: 10.13130/rd_unimi/ewftha/ex5nil
title: Febbraio_1906_Pagina_044.jpg

description: Bulletin of 1906/02/11
DOI: 10.13130/rd_unimi/zbysir/ekudiu
title: Febbraio_1900_Pagina_054.jpg

description: Bulletin of 1900/02/14
DOI: 10.3535/h2h-nv6-xq7
title: Solenobia lichenella

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/pn0-bsm-vsz
title: Syngrapha interrogationis (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.13130/rd_unimi/6g4l2b/elvq4w
title: Febbraio_1904_Pagina_053.jpg

description: Bulletin of 1904/02/14
DOI: 10.13130/rd_unimi/ewftha/t5yegx
title: Febbraio_1906_Pagina_045.jpg

description: Bulletin of 1906/02/12
DOI: 10.3535/2af-1sl-x70
title: Lycaenidae

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.